SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-002652
Filing Date
2022-01-19
Accepted
2022-01-19 15:48:03
Documents
44
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1121_bespoke.htm   iXBRL 10-Q 379410
2 CERTIFICATION f10q1121ex31-1_bespoke.htm EX-31.1 10590
3 CERTIFICATION f10q1121ex32-1_bespoke.htm EX-32.1 3836
  Complete submission text file 0001213900-22-002652.txt   2682236

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20211130.xsd EX-101.SCH 32493
5 XBRL CALCULATION FILE bspk-20211130_cal.xml EX-101.CAL 21580
6 XBRL DEFINITION FILE bspk-20211130_def.xml EX-101.DEF 162317
7 XBRL LABEL FILE bspk-20211130_lab.xml EX-101.LAB 319720
8 XBRL PRESENTATION FILE bspk-20211130_pre.xml EX-101.PRE 170503
38 EXTRACTED XBRL INSTANCE DOCUMENT f10q1121_bespoke_htm.xml XML 175991
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52759 | Film No.: 22538585
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences